A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim lesions.| Multiple Sclerosis News Today
Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, per an analysis.| Multiple Sclerosis News Today
Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while living with MS.| Multiple Sclerosis News Today
People with MS who experience chronic lower body pain have altered gait patterns, walking more slowly than those without this symptom.| Multiple Sclerosis News Today
Task-oriented training may help balance issues for people with MS, but current evidence is inconsistent, a study found.| Multiple Sclerosis News Today
Ibudilast was shown on MRI scans to slow the growth of chronic active lesions in the brains of progressive MS patients in the SPRINT-MS trial.| Multiple Sclerosis News Today
The presence of two distinct chronic lesion markers on MRI is linked to faster disability progression in MS patients, researchers say.| Multiple Sclerosis News Today
If you've just received a multiple sclerosis (MS) diagnosis, a good place to start is by gathering info on MS and how to best manage it.| Multiple Sclerosis News Today
Transcranial direct current stimulation (tDCS) didn't outperform a sham treatment in easing fatigue in adults with multiple sclerosis.| Multiple Sclerosis News Today
Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says.| Multiple Sclerosis News Today
In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain tissue, per a study.| Multiple Sclerosis News Today
Columnist Ben Hofmeister offers insight into his strategy of learning about MS care by using knowledge he already has.| Multiple Sclerosis News Today
Marisa Wexler is a senior science writer for Multiple Sclerosis News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of multiple sclerosis topics.| Multiple Sclerosis News Today
Migraines affect around 24% of people with MS, and are about two times more likely to occur in these patients than in healthy individuals.| Multiple Sclerosis News Today
There are several approved MS medications, from disease-modifying therapies to symptomatic treatments. Learn more about them here.| Multiple Sclerosis News Today
Fampyra (fampridine), which is approved to boost walking ability in adults with MS, may help people with poor working memory, a study says.| Multiple Sclerosis News Today
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.| Multiple Sclerosis News Today
Fatigue was shown to be a significant predictor of worse health-related quality of life in adults with relapsing-remitting multiple sclerosis.| Multiple Sclerosis News Today
Patricia Inacio is a science writer for Multiple Sclerosis News Today with a PhD in cell biology. She covers the latest news and information on a variety of multiple sclerosis topics.| Multiple Sclerosis News Today
Columnist Desiree Lama shares how a diagnosis of MS both halted her from scholastic pursuits and shifted her in a new direction.| Multiple Sclerosis News Today
Support and companionship are just a few benefits of having a cat, says columnist Desiree Lama, who writes about her furry friend, Lucky.| Multiple Sclerosis News Today
Columnist Susan Payrovi discovers how her body prefers to follow natural circadian rhythms, or biological clocks.| Multiple Sclerosis News Today
Learning to say no and prioritize her health has been crucial for columnist Desiree Lama, who lives with relapsing-remitting MS.| Multiple Sclerosis News Today
Category archive page for News.| Multiple Sclerosis News Today
In her columns debut, Desiree Lama shares the story of how vision loss and optic neuritis led to her multiple sclerosis diagnosis in 2016.| Multiple Sclerosis News Today
Spending time outdoors helps columnist Susan Payrovi wake up her body systems and manage her multiple sclerosis symptoms.| Multiple Sclerosis News Today
No one knows your needs as well as you do, says columnist Ben Hofmeister. That's why self-advocating is crucial when living with MS.| Multiple Sclerosis News Today
After a year, patients given CNM-Au8 had improvements in vision and data suggested the therapy improved the health of brain nerve fibers.| Multiple Sclerosis News Today
Certain immune cells are able to take on healing abilities allowing them to repair damaged nerve fibers, a possible strategy for treating MS.| Multiple Sclerosis News Today
The relationship between cognitive issues and quality of life was analyzed with a survey of 6,227 people using the NARCOMS registry.| Multiple Sclerosis News Today
A $2.9 million research grant will fund a project aiming to advance a new technology to improve stem cell therapies for multiple sclerosis.| Multiple Sclerosis News Today
Most nonactive SPMS patients who took foralumab nasal spray for at least six months saw a decrease in microglial activity in their brains.| Multiple Sclerosis News Today
Cognitive rehabilitation, with or without aerobic exercise, led to increased tissue volume and activity in brain regions linked to cognition.| Multiple Sclerosis News Today
Many MS patients experience primary headaches, and disease-modifying therapies may play different roles in their development, per a study.| Multiple Sclerosis News Today
Before MS, columnist Susan Payrovi thrived after dark. Now, she's honoring her body's rhythms and reaping the benefits of natural light.| Multiple Sclerosis News Today